{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:50:50Z","timestamp":1769104250909,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.bbr.2019.112380","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T11:54:37Z","timestamp":1574423677000},"page":"112380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Behavioral effects of buspirone in a mouse model of posttraumatic stress disorder"],"prefix":"10.1016","volume":"381","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1250-7768","authenticated-orcid":false,"given":"Natalia","family":"Malikowska-Racia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3974-8553","authenticated-orcid":false,"given":"Piotr","family":"Popik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0614-5393","authenticated-orcid":false,"given":"Kinga","family":"Sa\u0142at","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2019.112380_bib0005","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/da.20767","article-title":"Considering PTSD for DSM-5","volume":"28","author":"Friedman","year":"2011","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.bbr.2019.112380_bib0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1192\/bjp.bp.114.148551","article-title":"Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis","volume":"206","author":"Hoskins","year":"2015","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112380_bib0015","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/da.22511","article-title":"Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: systemic review and meta-analyses to determine first-line treatments","volume":"33","author":"Lee","year":"2016","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.bbr.2019.112380_bib0020","article-title":"PTSD: from neurobiology to pharmacological treatments","volume":"7","author":"Kelmendi","year":"2016","journal-title":"Eur. J. Psychotraumatol."},{"key":"10.1016\/j.bbr.2019.112380_bib0025","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fphar.2019.00404","article-title":"Therapeutic challenges of post-traumatic stress disorder: focus on the dopaminergic system","volume":"10","author":"Torrisi","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbr.2019.112380_bib0030","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1038\/s41467-018-06785-y","article-title":"Dopamine-dependent prefrontal reactivations explain long-term benefit of fear extinction","volume":"9","author":"Gerlicher","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbr.2019.112380_bib0035","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1176\/appi.ajp.2009.09081168","article-title":"Emotion modulation in PTSD: clinical and neurobiological evidence for a dissociative subtype","volume":"167","author":"Lanius","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112380_bib0040","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/npp.2015.282","article-title":"Randomized placebo-controlled trial of methylphenidate or galantamine for persistent emotional and cognitive symptoms associated with PTSD and\/or traumatic brain injury","volume":"41","author":"McAllister","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2019.112380_bib0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/1099-1077(200006)15:4<295::AID-HUP166>3.0.CO;2-O","article-title":"The use of stimulants in the treatment of post traumatic stress disorder: case report","volume":"15","author":"Daly","year":"2000","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.bbr.2019.112380_bib0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/JCP.0b013e318032eaed","article-title":"A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder","volume":"27","author":"Becker","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbr.2019.112380_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2019.05.012","article-title":"Dopamine D2\/D3 receptor agonists attenuate PTSD-like symptoms in mice exposed to single prolonged stress","volume":"155","author":"Malikowska-Racia","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2019.112380_bib0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2012.04.032","article-title":"Buspirone: What is it all about?","volume":"1461","author":"Loane","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2019.112380_bib0065","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1017\/S1461145714000194","article-title":"Therapeutic doses of buspirone block D3 receptors in the living primate brain","volume":"17","author":"Kim","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2019.112380_bib0070","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1007\/s00213-017-4715-5","article-title":"The effects of buspirone on occupancy of dopamine receptors and the rat gambling task","volume":"234","author":"Di Ciano","year":"2017","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2019.112380_bib0075","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3389\/fphar.2017.00710","article-title":"Buspirone counteracts MK-801-Induced schizophrenia-like phenotypes through dopamine D3 receptor blockade","volume":"8","author":"Torrisi","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbr.2019.112380_bib0080","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/npp.2014.300","article-title":"Effects of oral and intravenous administration of buspirone on food\u2013Cocaine choice in socially housed male Cynomolgus monkeys","volume":"40","author":"Czoty","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2019.112380_bib0085","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1038\/npp.2014.51","article-title":"Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone","volume":"39","author":"Leggio","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2019.112380_bib0090","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1037\/pha0000209","article-title":"Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys","volume":"26","author":"Collins","year":"2018","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbr.2019.112380_bib0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10401239409148837","article-title":"Efficacy of buspirone in the treatment of posttraumatic stress disorder: an open trial","volume":"6","author":"Duffy","year":"1994","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112380_bib0100","series-title":"The Management of Posttraumatic Stress Disorder Work Group (2017) VA\/DOD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder","author":"The Management of Posttraumatic Stress Disorder Work Group","year":"2017"},{"key":"10.1016\/j.bbr.2019.112380_bib0105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bbr.2016.01.056","article-title":"Severe, multimodal stress exposure induces PTSD-like characteristics in a mouse model of single prolonged stress","volume":"303","author":"Perrine","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.112380_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2019.02.005","article-title":"Coping with the forced swim stressor: current state-of-the-art","volume":"364","author":"Molendijk","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.112380_bib0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnbeh.2016.00038","article-title":"Contextual modulation of vocal behavior in mouse: newly identified 12 kHz \u2018Mid-Frequency\u2019 vocalization emitted during restraint","volume":"10","author":"Grimsley","year":"2016","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.bbr.2019.112380_bib0120","first-page":"375","article-title":"Effects of buspirone on dopamine dependent behaviours in rats","volume":"51","author":"Dhavalshankh","year":"2007","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbr.2019.112380_bib0125","first-page":"704","article-title":"Dose-dependent response of central dopaminergic systems to buspirone in mice","volume":"46","author":"Jadhav","year":"2008","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.bbr.2019.112380_bib0130","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature."},{"key":"10.1016\/j.bbr.2019.112380_bib0135","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/35021052","article-title":"Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval","volume":"406","author":"Nader","year":"2000","journal-title":"Nature."},{"key":"10.1016\/j.bbr.2019.112380_bib0140","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Th\u00e9rapie."},{"key":"10.1016\/j.bbr.2019.112380_bib0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbr.2019.112380_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155759","article-title":"Impaired ethanol-induced sensitization and decreased cannabinoid Receptor-1 in a model of posttraumatic stress disorder","volume":"11","author":"Matchynski-Franks","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2019.112380_bib0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nlm.2013.11.014","article-title":"From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders","volume":"113","author":"VanElzakker","year":"2014","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.bbr.2019.112380_bib0160","doi-asserted-by":"crossref","first-page":"e700","DOI":"10.1038\/tp.2015.196","article-title":"Fear learning circuitry is biased toward generalization of fear associations in posttraumatic stress disorder","volume":"5","author":"Morey","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112380_bib0165","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/wps.20150","article-title":"How well can post-traumatic stress disorder be predicted from pre-trauma risk factors? An exploratory study in the WHO World Mental Health Surveys","volume":"13","author":"Kessler","year":"2014","journal-title":"World Psychiatry"},{"key":"10.1016\/j.bbr.2019.112380_bib0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pnpbp.2018.11.010","article-title":"Genomic updates in understanding PTSD","volume":"90","author":"Sharma","year":"2019","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry."},{"key":"10.1016\/j.bbr.2019.112380_bib0175","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/070674371405900902","article-title":"Posttraumatic stress disorder in adults: impact, comorbidity, risk factors, and treatment","volume":"59","author":"Sareen","year":"2014","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112380_bib0180","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0006-3223(93)90290-T","article-title":"5-HT1A agonists disrupt memory of fear conditioning in mice","volume":"33","author":"Quartermain","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112380_bib0185","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.npp.1300079","article-title":"GABA-A and 5-HT1A receptor agonists block expression of fear-potentiated startle in mice","volume":"28","author":"Risbrough","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2019.112380_bib0190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1520-6394(1997)5:3<137::AID-DA6>3.0.CO;2-B","article-title":"Buspirone potentiation of antidepressants in the treatment of PTSD","volume":"5","author":"Hamner","year":"1997","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.bbr.2019.112380_bib0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004714-199204000-00010","article-title":"Buspirone in the treatment of posttraumatic stress disorder","volume":"12","author":"Laporta","year":"1992","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbr.2019.112380_bib0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/00044011-200424020-00007","article-title":"Tandospirone in the treatment of generalised anxiety disorder and mixed anxiety-depression","volume":"24","author":"Nishitsuji","year":"2004","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.bbr.2019.112380_bib0205","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1440-1819.2003.01099.x","article-title":"Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial","volume":"57","author":"Yamada","year":"2003","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbr.2019.112380_bib0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpsychires.2019.04.024","article-title":"A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: a pilot randomized controlled trial at a single-center in China","volume":"114","author":"Chen","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbr.2019.112380_bib0215","first-page":"1","article-title":"A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult chinese patients with treatment-resistant major depression","author":"Fang","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbr.2019.112380_bib0220","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/jm101459g","article-title":"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder","volume":"54","author":"Bang-Andersen","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbr.2019.112380_bib0225","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2005.01.018","article-title":"Neurochemical evaluation of the novel 5-HT1A receptor partial agonist\/serotonin reuptake inhibitor, vilazodone","volume":"510","author":"Hughes","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2019.112380_bib0230","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2019.112380_bib0235","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0091-3057(96)00116-5","article-title":"Buspirone enhances immobility in the forced swim test in mice","volume":"55","author":"Kitamura","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2019.112380_bib0240","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuropharm.2011.03.004","article-title":"5-HT1A-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test","volume":"61","author":"G\u00fcnther","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2019.112380_bib0245","article-title":"Anxiolytic effects of buspirone and MTEP in the porsolt forced swim test","volume":"1","author":"Lee","year":"2017","journal-title":"Chronic Stress (Thousand Oaks)"},{"key":"10.1016\/j.bbr.2019.112380_bib0250","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s002130050578","article-title":"Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients","volume":"136","author":"Laakmann","year":"1998","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2019.112380_bib0255","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00004714-199002000-00002","article-title":"Is buspirone effective for panic disorder?","volume":"10","author":"Sheehan","year":"1990","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbr.2019.112380_bib0260","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000284627","article-title":"Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone","volume":"22","author":"Pohl","year":"1989","journal-title":"Psychopathology"},{"key":"10.1016\/j.bbr.2019.112380_bib0265","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010828.pub2","article-title":"Azapirones versus placebo for panic disorder in adults","author":"Imai","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbr.2019.112380_bib0270","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0028-3908(97)00094-4","article-title":"Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze","volume":"36","author":"Cao","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2019.112380_bib0275","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0166-4328(03)00184-0","article-title":"Use of the elevated T-maze to study anxiety in mice","volume":"148","author":"Carvalho-Netto","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.112380_bib0280","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbr.2013.04.014","article-title":"The anxiolytic buspirone shifts coping strategy in novel environmental context of mice with different anxious phenotype","volume":"250","author":"Horv\u00e1th","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.112380_bib0285","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/j.1875-9114.1991.tb04299.x","article-title":"Buspirone in the treatment of posttraumatic stress disorder","volume":"11","author":"Wells","year":"1991","journal-title":"Pharmacotherapy"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432819314482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432819314482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:16:37Z","timestamp":1759065397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432819314482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":57,"alternative-id":["S0166432819314482"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2019.112380","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioral effects of buspirone in a mouse model of posttraumatic stress disorder","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2019.112380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112380"}}